ТИРОНЕТ – все о щитовидной железе Для специалистов Журнал Тиронет 2012 год № 2
Чрескожная абляция этанолом в лечении метастазов папиллярного рака щитовидной железы в лимфатические узлы шеи
Кэролайн Давидж-Питтс, Роберт Ли и Ян Хей
1. Отделение эндокринологии, диабета, метаболизма и питания
2. Отделение внутренних болезней и УЗИ-диагностики
3. Отделение радиологии, клиника Мейо и медицинский колледж Мейо, Рочестер, Миннесота
Литература
1. Schlumberger MJ, Filetti S, Hay ID. Non-toxic diffuse and nodular goiter and thyroid neoplasia. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, editors. Williams Textbook of Endocrinology, 12th ed. Philadelphia: Elsevier Saunders; 2011, p 440-478.
2. Hundahl SA, Fleming ID, Fremgen AM. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S, 1985-1995, Cancer 1998; 83: 2638-2648.
3. Ebihara S, Saikawa M. Survey and analysis of thyroid carcinoma by the Japanese Society of Thyroid Surgery. Thyroidal Clin Exp 1998; 10: 85-91.
4. Grebe SKG, Hay ID. Thyroid cancer nodal metastases: biological significance and therapeutic consideration. Surg Clin North Am 1996; 5: 43-63.
5. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990; 19: 545-576.
6. Hay ID. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic’s experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Amer Clin Climatol Assoc 2002; 113: 241-260.
7. Livraghi T, Paracchi A, Ferrari C et al. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Radiology 1990; 175: 827-829.
8. Martino E, Bogazzi F. Percutaneous ethanol injection therapy for thyroid diseases. Thyroid International 2000; 5: 1-12.
9. Hay ID, Charboneau JW. The coming of age of ultrasound-guided percutaneous ethanol ablation of selected neck nodal metastases in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 2011; 96: 2717-2720.
10. Hay ID. Ablative percutaneous ultrasound-guided ethanol injection for neck nodal metastases in papillary and sporadic medullary thyroid carcinoma. In: Randolph GW, editor. Surgery of the thyroid and parathyroid glands. 2nd ed. Philadelphia: Saunders; 2012, p.511-519.
11. Hay ID. Managing patients with a preoperative diagnosis of AJCC/ UICC stage I (T1N0M0) papillary thyroid carcinoma: East versus West, whose policy is best? World J Surg 2010; 34: 1291-1293.
12. Cooper DS, Doherty GM, Haugen BR, et al. Revised ATA management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009: 19: 1167-1214.
13. Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006: 154: 787-803.
14. Tuttle RM, Ball DW, Byrd D, et al. Thyroid carcinoma. J Natl Compr Canc Netw 2010; 8: 1228-1274.
15. Rondeau G, Tuttle RM. Similarities and differences in follicular cell-derived thyroid cancer management guidelines used in Europe and the United States. Semin Nucl Med 2011; 41: 89-95.
16. Hay ID. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol 2007; 94: 692-700.
17. Sacks W, Fung CH, Chang JT, et al. The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008. Thyroid 2010; 20: 1235-1245.
18. Mazzaferri EL, Young RL, Oertel JE et al. Papillary thyroid carcinoma: the impact of treatment in 576 patients. Medicine (Baltimore) 1977; 56: 171-196.
19. Mazzaferri EL. Empirically treating high serum thyroglobulin levels. J Nucl Med 2005; 46: 1079-1088.
20. Sisson JC. Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected. J Nucl Med 1983; 24: 743-745.
21. Torlontano M, Attard M, Crocetti U et al. Follow-up of low-risk patients with PTC: role of neck ultrasound in detecting lymph nodal metastases. J Clin Endocrinol Metab 2004: 89: 3402-3407.
22. Robenshtok E, Fish S, Bach A, Dominguez JM, Shaha A, Tuttle RM. Suspicious lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab 2012; 97: 2706-2713.
23. Al-Saif O, Farrar WB, Blooms ton M et al. Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab 2010; 95: 2187-2194.
24. Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol 2002; 178: 699-704.
25. Charboneau JW, Hay ID, van Heerden JA. Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma. Mayo Clin Proc 1988; 63:913-91.
26. Solbiati L, Charboneau JW, Reading CC, James EM, Hay ID. The thyroid gland. In: Rumack CM, Wilson SR, Charboneau JW, Levine D, editors. Diagnostic Ultrasound, 4th ed. Philadelphia: Elsevier Mosby; 2011, p. 708-749.
27. Livraghi T, Festi D, Monti F, Salmi A, Vettori C. US-guided percutaneous ethanol injection of small hepatic and abdominal tumors. Radiology 1986; 161: 309-312.
28. Levy MJ, Thompson GB, Topazian MD, Callstrom MR, Grant CS, Vella A. US-guided ablation of insulinomas: a new treatment option. Gastrointestinal Endoscopy 2012: 12:200-206.
29. Burman KD. Treatment of recurrent or persistent cervical node metastases in differentiated thyroid cancer: deceptively simple options. J Clin Endocrinol Metab 2012; 97: 2623-2625.
30. Monchik JM, Donatini G, Iannucilli J, Dupuy DE. Radiofrequency ablation and percutaneous ethanol injection for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 2006; 244: 296-304.
31. Lim CY, Yun J-S, Lee J et al. Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid 2007; 17: 347-350.
32. Kim BM, Kim MJ, Kim E-K et al. Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol 2008; 18: 835-842.
33. Heilo A, Sigstad E, Fagerlid KH et al: Efficacy of ultrasoundguided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab 2011: 96:2750-5.
34. Hay ID, Reading CC, Lee RA, Gonzalez Losada T, Charboneau. Ultrasound-guided percutaneous ethanol injection: an effective longterm solution for selected persistent neck nodal metastases in pTNM stage I papillary thyroid carcinoma patients treated by surgery and radioiodine remnant ablation. Proceedings of the 28th Annual Meeting, American Association of Endocrine Surgeons, Tucson, Arizona, April 29-May 1, 2007.
